U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
3861138611A Phase I Clinical Trial to Investigate the Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male SubjectsNot yet recruitingNo Results AvailableHealthyDrug: administration of exforge 10/160mg for 3days. Next 7days administration of exforge 10/160mg and crestor 20mg.https://ClinicalTrials.gov/show/NCT02060019
3861238612TB-IRIS NSAID Cox-2 Inhibitor Prevention TrialRecruitingNo Results AvailableTuberculosisDrug: Meloxicam 7.5mg daily for 8 weekshttps://ClinicalTrials.gov/show/NCT02060006
3861338613The Effects of Obstructive Sleep Apnea and Its Intervention on Coronary Heart DiseaseCompletedHas ResultsHypertension|Metabolic DisorderDevice: continuous positive airway pressurehttps://ClinicalTrials.gov/show/NCT02059993
3861438614Developing Effective Response Inhibition Training for Symptom Relief in OCD and TrichotillomaniaRecruitingNo Results AvailableObsessive Compulsive Disorder|TrichotillomaniaBehavioral: Response inhibition training|Behavioral: Placebo Control Traininghttps://ClinicalTrials.gov/show/NCT02059980
3861538615Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLCWithdrawnNo Results AvailableAdenocarcinoma of the Lung|Large Cell Lung Cancer|Squamous Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung CancerDrug: Paclitaxel|Radiation: image-guided adaptive radiation therapy|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT02059967
3861638616Vaginal vs. Laparoscopic HysterectomyRecruitingNo Results AvailableUterine Fibroids|Uterine Leiomyoma|Abnormal Uterine Bleeding, UnspecifiedProcedure: Hysterectomyhttps://ClinicalTrials.gov/show/NCT02059954
3861738617Managing Severe Traumatic Brain Injury (TBI) Without Intracranial Pressure Monitoring (ICP) Monitoring GuidelinesRecruitingNo Results AvailableTraumatic Brain Injuryhttps://ClinicalTrials.gov/show/NCT02059941
3861838618Intraosseous Pressure Monitoring in Intensive Care Unit PatientsRecruitingNo Results AvailableInfusions, Intraosseous|Central Venous Pressure|Blood PressureDevice: Intraosseous Devicehttps://ClinicalTrials.gov/show/NCT02059928
3861938619Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted ConditionsCompletedNo Results AvailableHealthyDrug: Oxycodone|Drug: Oxycodone|Drug: Oxycodone|Drug: Oxycodonehttps://ClinicalTrials.gov/show/NCT02059915
3862038620Continuous Lidocaine Infusion for Management of Perioperative Burn PainCompletedNo Results AvailableThermal BurnsDrug: Lidocainehttps://ClinicalTrials.gov/show/NCT02059902
3862138621Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung CancerEnrolling by invitationNo Results AvailableRecurrent Non-small Cell Lung Cancer|Stage IIA Non-small Cell Lung Cancer|Stage IIB Non-small Cell Lung Cancer|Stage IIIA Non-small Cell Lung Cancer|Stage IIIB Non-small Cell Lung CancerDevice: diffusion-weighted magnetic resonance imaging|Device: 4-dimensional computed tomography|Radiation: fludeoxyglucose F 18|Device: FDG-PEThttps://ClinicalTrials.gov/show/NCT02059889
3862238622Dose-dense (Biweekly) Carboplatin Plus Paclitaxel With or Without Trastuzumab as Neoadjuvant Treatment for Breast CancerRecruitingNo Results AvailableBreast CancerDrug: carboplatin and paclitaxel and or without trastuzumabhttps://ClinicalTrials.gov/show/NCT02059876
3862338623SPRING Cluster Randomised Controlled TrialNot yet recruitingNo Results AvailableGrowth; Stunting, Nutritional|Child Development|Depression, Postpartum|DeathBehavioral: SPRINGhttps://ClinicalTrials.gov/show/NCT02059863
3862438624NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaRecruitingNo Results AvailableAdult Synovial Sarcoma|Myxoid/Round Cell Liposarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue Sarcoma|Stage IV Adult Soft Tissue SarcomaBiological: Autologous NY-ESO-1-specific CD8-positive T Lymphocytes|Drug: Cyclophosphamide|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT02059850
3862538625Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium SurgeryCompletedNo Results AvailableRecurrent PterygiumProcedure: recurrent pterygium excision and following graftinghttps://ClinicalTrials.gov/show/NCT02059837
3862638626Normal Eyelid Sensation DistributionCompletedNo Results AvailableNormal Eyelid Sensation DistributionDevice: Aesthesiometerhttps://ClinicalTrials.gov/show/NCT02059824
3862738627Efficacy and Safety of the DASH Diet in Adults With Moderate Chronic Kidney Disease: Pilot StudyCompletedNo Results AvailableHypertension|Chronic Kidney DiseaseOther: DASH Diet|Other: Control Diethttps://ClinicalTrials.gov/show/NCT02059811
3862838628Urinary and Sexual Function Before and After Surgical Decompression of Cervical MyelopathyNot yet recruitingNo Results AvailableMyelopathy|Neurogenic Bladder|Erectile Dysfunction|Psychosexual Dysfunctions|Sexual Arousal Disorderhttps://ClinicalTrials.gov/show/NCT02059798
3862938629Phase â…¡Study of Pinocembrin Injection to Treat Ischemic StrokeRecruitingNo Results AvailableIschemic StrokeDrug: Pinocembrin for Injectionhttps://ClinicalTrials.gov/show/NCT02059785
3863038630Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular EdemaRecruitingNo Results AvailableDiabetic Macular EdemaDrug: ranibizumab|Procedure: micropulse diode laserhttps://ClinicalTrials.gov/show/NCT02059772
3863138631Immuno-modulation in Amyotrophic Lateral Sclerosis- a Phase II Study of Safety and Activity of Low Dose Interleukin-2RecruitingNo Results AvailableAmyotrophic Lateral SclerosisDrug: Placebo|Drug: 1.0 MIU IL-2 per day|Drug: 2.0 MIU IL-2 per dayhttps://ClinicalTrials.gov/show/NCT02059759
3863238632Perineal Consequences of Twin Pregnancies According to Mode of DeliveryActive, not recruitingNo Results AvailablePregnancy, MultipleOther: Questionnaires sent by mailhttps://ClinicalTrials.gov/show/NCT02059746
3863338633Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and Parkinsonism by 18F-DTBZ PETRecruitingNo Results AvailableParkinson's DiseaseDrug: 18F-DTBZhttps://ClinicalTrials.gov/show/NCT02059733
3863438634Haplo-SCT vs ASCT With or Without Decitabine in AML CR1RecruitingNo Results AvailableAcute Myeloid LeukemiaProcedure: HSCThttps://ClinicalTrials.gov/show/NCT02059720
3863538635LARIAT RS: An Observational Study of the Performance and Safety of the LARIAT RSEnrolling by invitationNo Results AvailableAtrial AppendageDevice: LARIAT RS Suture Delivery Devicehttps://ClinicalTrials.gov/show/NCT02059707
3863638636Use of Recombinant Hyaluronidase Human is Effective for the Use of Local Blocks for Eyelid's SurgeryWithdrawnNo Results AvailableUpper Eyelid SurgeryDrug: Hyaluronidase|Other: 2 mL of lidocaine 2% with epinephrine 1:100,000 without rHuPH20https://ClinicalTrials.gov/show/NCT02059694
3863738637Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)RecruitingNo Results AvailableChronic Myocardial IschemiaOther: Autologous bone marrow derived-CD133+ cellshttps://ClinicalTrials.gov/show/NCT02059681
3863838638Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)RecruitingNo Results AvailableHead and Neck CancerBiological: Biomarker analyses head & neck cancer tissue, blood specimenhttps://ClinicalTrials.gov/show/NCT02059668
3863938639Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study)Active, not recruitingNo Results AvailableGraves' OphthalmopathyDrug: Bimatoprost|Drug: Eye drop solutionhttps://ClinicalTrials.gov/show/NCT02059655
3864038640A 6 Week Randomized Study of MG01CI 1400 mg Compared With Placebo in Adults With ADHD (Adults With Attention Deficit/Hyperactivity )CompletedNo Results AvailableADHD|Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeDrug: MG01CI (1400 mg)|Drug: placebohttps://ClinicalTrials.gov/show/NCT02059642

* Görseller ve İçerik tekif hakkına sahip olabilir